Women's Health - Medical Affairs Consultant & OB/GYN, Small / Medium Biotech

A Medical Affairs consultant at a small / medium biotech company and former OB/GYN(practiced 19 years) has expertise across precision medicine, including hereditary cancers,oncology, the direct-to-consumer space, and endometriosis. Key challenges in the women’shealth space are considered insufficient investment, lacking prognostic tests, no gold standardsfor testing and treatment, regulatory / reimbursement barriers, and limited access to care. Theyconsider investment from the private sector to be more of a challenge compared to publicfunding. They believe unmet needs are highest in endometriosis, PCOS, pregnancycomplications, menstrual health, and menopause, and believe precision medicine activity will behighest in endometriosis and fertility. This stakeholder is excited by activity from 3Daughtersand Luna Genetics, but notes that the recent political climate post-Roe has created challengesfor NIPT. They believe the increasing number of female founders and CEOs will be a driver forinvestment and movement in the next 1-2 years.

‍